Invention Grant
- Patent Title: Isotopically enriched arylsulfonamide CCR3 antagonists
- Patent Title (中): 同位素富集的芳基磺酰胺CCR3拮抗剂
-
Application No.: US13038251Application Date: 2011-03-01
-
Publication No.: US08999995B2Publication Date: 2015-04-07
- Inventor: Tai Wei Ly , Garrett Thomas Potter
- Applicant: Tai Wei Ly , Garrett Thomas Potter
- Applicant Address: US CA San Diego
- Assignee: Axikin Pharmaceuticals, Inc.
- Current Assignee: Axikin Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- Main IPC: A61K31/495
- IPC: A61K31/495 ; C07D295/26 ; C07B59/00
Abstract:
Provided herein are isotopically enriched arylsulfonamides, for example, of Formula I, that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
Public/Granted literature
- US20110218207A1 ISOTOPICALLY ENRICHED ARYLSULFONAMIDE CCR3 ANTAGONISTS Public/Granted day:2011-09-08
Information query
